Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome
about
Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi JewsMonolysocardiolipin in cultured fibroblasts is a sensitive and specific marker for Barth SyndromeComparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomographyOnly one splice variant of the human TAZ gene encodes a functional protein with a role in cardiolipin metabolismRole of calcium-independent phospholipase A2 in the pathogenesis of Barth syndromeCharacterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiencyBarth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirthFormation of molecular species of mitochondrial cardiolipin. 1. A novel transacylation mechanism to shuttle fatty acids between sn-1 and sn-2 positions of multiple phospholipid speciesThe cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndromeCharacterization of tafazzin splice variants from humans and fruit fliesShotgun lipidomics of cardiolipin molecular species in lipid extracts of biological samplesAlterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics studyAltered Traffic of Cardiolipin during Apoptosis: Exposure on the Cell Surface as a Trigger for "Antiphospholipid Antibodies"Mitochondrial dynamism and heart disease: changing shape and shaping changeRespiratory supercomplexes: plasticity and implicationsBarth syndrome.The translocator maintenance protein Tam41 is required for mitochondrial cardiolipin biosynthesis.Mitochondrial mislocalization and altered assembly of a cluster of Barth syndrome mutant tafazzinsCardiolipin mediates cross-talk between mitochondria and the vacuole.Identification of a cardiolipin-specific phospholipase encoded by the gene CLD1 (YGR110W) in yeastTaz1, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth SyndromeAim24 and MICOS modulate respiratory function, tafazzin-related cardiolipin modification and mitochondrial architectureMisregulation of a DDHD Domain-containing Lipase Causes Mitochondrial Dysfunction in YeastMonolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosisX-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an updateThe enzymatic function of tafazzinComplex expression pattern of the Barth syndrome gene product tafazzin in human cell lines and murine tissuesCardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagyLPS impairs oxygen utilization in epithelia by triggering degradation of the mitochondrial enzyme Alcat1Cardiolipin fingerprinting of leukocytes by MALDI-TOF/MS as a screening tool for Barth syndromeDisorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genesMetabolomics Reveals New Mechanisms for Pathogenesis in Barth Syndrome and Introduces Novel Roles for Cardiolipin in Cellular FunctionCellular functions of cardiolipin in yeastThe importance of cardiolipin synthase for mitochondrial ultrastructure, respiratory function, plant development, and stress responses in ArabidopsisCardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and functionAssessing phospholipase A2 activity toward cardiolipin by mass spectrometryCardiolipin at the heart of stress response across kingdomsComparative gene identification-58 (CGI-58) promotes autophagy as a putative lysophosphatidylglycerol acyltransferaseHistorical perspective on mitochondrial medicineCardiolipin stabilizes respiratory chain supercomplexes
P2860
Q24291826-C638D4B1-4A2B-448E-A6AE-15B9E2359D6BQ24298288-4E5193BC-F19F-413C-A986-33380293E7A5Q24306890-1AC526D3-08D1-44FD-ACC9-C136A91651E8Q24317315-E2427C0D-550E-4EFC-8FEC-D426BDE95CC6Q24320205-8B286B01-E528-4E04-92BE-70C95AFD55A4Q24604918-AF9BCAB1-18C1-4776-90AA-709F7606732FQ24632525-052A0096-EC3E-4B92-A82C-C625BD76F2BEQ24647646-E42F98C5-36AD-4DCB-BB79-47023D14139CQ24651872-9879BE03-4BCF-4028-8092-1E7FABF74021Q24652344-5B5890FC-C4F8-4A20-9C0C-EC234B114DCEQ24671079-8758B13A-063A-4AA9-81E9-87D4DA509C6AQ24678475-39899908-6EFC-46E6-BCDC-F548071F3F04Q26780481-80B8D658-7ED4-4390-9962-F6AC54623C46Q26825299-0526804E-C20F-47F1-95E0-5D7BBC401CE0Q27010216-BC561C73-BCB8-4C05-ACC4-94301C04C5B9Q27692590-B577F46C-5B10-4C1D-AF66-133FE8D386B4Q27929808-833FC2F7-FA01-4921-B525-86D3781B5A46Q27930348-A1D9A3E6-2247-451B-93C1-A1A144BEA92BQ27931149-C51048BE-FD1B-4CC0-82FC-64B12D92A076Q27934941-5D134461-BE32-46FA-AA45-8B3323E5C237Q27936928-0EEA8808-F12B-41F0-A16B-51162A251C5CQ27938907-F8FA8CFF-A4F2-455C-A8B0-2C7906F68EC6Q27939229-23DE1332-8A84-494F-8249-D7D240912E58Q28243113-48D6DD9F-9CF6-4DF4-9D35-D898F236B0A5Q28257595-0FEB7968-A94E-4431-B6D3-B721819622ACQ28272001-CB6A9B70-E4A9-47D3-9BBC-01719F7347E1Q28289152-AD700F8B-EA0A-4F66-B4A1-8AEFE54D0F11Q28383403-697AF989-1E30-4276-B11B-58B59EA26857Q28385337-C2FE6E65-E77E-4ACD-B9E7-F20AEFE85721Q28386643-D3501270-BA1E-415E-9DA3-4DBAF15820B9Q28387241-0B1CC03B-1E16-49D4-A85E-007574D08C6FQ28390562-0BDC2F55-7A08-440D-AE83-5A63B7226157Q28392417-FB7C2162-32D4-4FD9-82C7-527EDB7B3577Q28393568-E884B3FD-3C84-436B-A7A6-EDA8593D8D89Q28395178-9BA0B556-1CCC-4159-9429-1DDA3AF95EC0Q28396086-9F08D5C2-652A-44DB-9DBC-958FD5225E86Q28396260-DE125D00-0773-472B-BAD4-B9B509CCA684Q28397954-D33E5467-3C74-4AB4-93FB-4A0CA72F9285Q28661465-F1D9EFFA-1A03-4883-B206-5A9B1AF7E7FAQ29615470-524C3F6A-EFC9-4B48-B607-A1DBB7F8D253
P2860
Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome
@ast
Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome
@en
Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome
@en-gb
Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome
@nl
type
label
Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome
@ast
Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome
@en
Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome
@en-gb
Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome
@nl
prefLabel
Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome
@ast
Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome
@en
Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome
@en-gb
Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome
@nl
P2093
P3181
P356
P1476
Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome
@en
P2093
F Valianpour
L A Grivell
L G Nijtmans
R J Wanders
P304
P3181
P356
10.1006/BBRC.2000.3952
P407
P577
2000-12-20T00:00:00Z